{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for cefadroxil in Related Substance Name (approximate match)
Status:
US Approved Rx
(2007)
Source:
ANDA065352
(2007)
Source URL:
First approved in 1978
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
Cefadroxil is a new semisynthetic cephalosporin with a broad antibacterial spectrum and a high chemotherapeutic potential when administered orally. Many studies have established the efficacy of the administration of once- or twice-daily cefadroxil in the management of infections in the respiratory tract, urinary tract, skin and soft tissues, and bones and joints.
Status:
Possibly Marketed Outside US
Source:
Thera Derm by Manna Omni International Incorporated
Source URL:
First approved in 2017
Source:
Thera Derm by Manna Omni International Incorporated
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
7-Aminodesacetoxycephalosporanic acid is a key intermediate for the synthesis of cephalosporins antibiotics and their intermediates. The current process for producing 7-ADCA involves a multistep chemical ring expansion of penicillin G to phenylacetyl-7-ADCA, from which the aromatic side chain is removed using a penicillin acylase.
